Tag: MIPS
IDT announces successful manufacture of Australia’s first mRNA COVID-19 vaccine candidate
It took just five months for Victorian scientists and manufacturers to develop Australia's first mRNA COVID-19 vaccine candidate — the country's first ever mRNA medicinal product – allowing...
IDT Australia ready to begin small-scale manufacturing of Australia’s first mRNA vaccine in preparation...
Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...
IDT in talks to manufacture Australia’s first COVID-19 vaccine candidate
Melbourne-based pharmaceutical manufacturer IDT Australia is locked in discussions with the Victorian Government, mRNA Victoria and the Monash Institute of Pharmaceutical Sciences (MIPS) to...
Monash awarded $5m grant to manufacture Australia’s first COVID-19 vaccine candidate
The Monash Institute of Pharmaceutical Sciences (MIPS) has received $5 million from the Victorian Government to manufacture doses of Australia’s first COVID-19 vaccine candidate...
Industry partnership yields high recognition
The Monash Institute of Pharmaceutical Sciences (MIPS) has received high recognition for the Monash-GSK Australian Center for Innovation and Industrialization Project aimed at developing...
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
